Medtronic MDT Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Cardiovascular | $3.8B+9.8% | $3.46B+0.6% | $3.44B+4.6% | $3.29B-1.5% | $3.34B+9.8% | |
| Diabetes | $838M+5.3% | $796M+5.2% | $757M+5.0% | $721M-1.0% | $728M+4.9% | |
| Medical Surgical | $2.39B+9.8% | $2.17B+0.1% | $2.17B+4.2% | $2.08B-5.8% | $2.21B+6.7% | |
| Neuroscience | $2.75B+7.5% | $2.56B-0.2% | $2.56B+6.0% | $2.42B-7.8% | $2.62B+6.6% | |
| Other Operating Segments | $33.75M0.0% | $33.75M0.0% | $33.75M0.0% | $33.75M-1.5% | $34.25M0.0% | |
| Net Sales by Geography | ||||||
| Ireland | $39M+8.3% | $36M+2.9% | $35M+6.1% | $33M+10.0% | $30M+7.1% | |
| Rest of world | $4.9B+9.2% | $4.49B+1.8% | $4.41B+2.1% | $4.32B-0.7% | $4.35B+8.0% | |
| United States | $4.87B+8.4% | $4.49B-0.5% | $4.52B+6.9% | $4.22B-7.1% | $4.55B+7.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Medtronic break its business down?
- Medtronic (MDT) reports net sales by business across 6 parts — Cardiovascular, Diabetes, Medical Surgical, Neuroscience and Other operating segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Medtronic's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Medtronic's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
